Organization
Aragon Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Aragon Pharmaceuticals, Inc.
... CSO. “The Column Group worked with Dr. Sawyers and Dr. Heyman at Aragon Pharmaceuticals and Seragon Pharmaceuticals, and we have tremendous confidence in their ability, ...
... Guidewire Software, Seragon / Aragon Pharmaceuticals, and WeWork will receive EY's 2015 Venture Capital Award of Excellence, ...
... Two Jinn; and (Not pictured) Dr. Rich Heyman, CEO - Seragon / Aragon Pharmaceuticals. (Photo: Business Wire) EY Entrepreneur Of The Year is the world's ...
... to joining ProNAi, Dr. You served as the Chief Business Officer of Aragon Pharmaceuticals, a private oncology drug discovery and development company, where she was ...
... contributed to the formation of startups, especially in biotechnology. The spinoffs include Aragon Pharmaceuticals, sold in 2013 to Johnson & Johnson for up to $1 ...
... experimental breast cancer treatment prove viable. Seragon was spun out of Aragon Pharmaceuticals Inc. after Johnson & Johnson agreed to buy Aragon last fall for ...
... cancer, Zytiga, and is committed to paying up to $1 billion for Aragon Pharmaceuticals' experimental prostate cancer drugs. But Molina thinks these therapies could be ...
... Janssen, as exemplified by the recent Johnson & Johnson acquisition of Aragon Pharmaceuticals, Inc. and ARN-509, an investigational second-generation androgen receptor signaling inhibitor. Janssen is ...
... Square, Beceem Communications, Xsigo Systems 64 Carl Gordon (New) OrbiMed Advisors Inhibitex, Aragon Pharmaceuticals, Adimab 65 Ron Conway (41) SV Angel Twitter, Zynga, Snapchat 66 ...
... Of Aragon Pharmaceuticals, Inc. . Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc. Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline NEW BRUNSWICK, N.J., Aug. ...
... Technidyne Corp., Intrinsic Bioprobes Inc., IRIS International Inc., Life Technologies Corp., Linkage Biosciences Inc., Luminex Corp., Magellan Biosciences Inc., Millipore Corp., Mitsubishi Chemical Medience Corp., ...
... front to license potential prostate cancer therapies from privately held biotech Aragon Pharmaceuticals Inc. That deal could amount to more than $1 billion. Up-front payments ...
... experienced life science executive who is currently chief exe cutive officer of Aragon Pharmaceuticals, which he co-founded in 2009 . In June 2013, Aragon announced ...
... New York. On June 17, an Aisling portfolio company in San Diego, Aragon Pharmaceuticals, which has a prostate cancer treatment in midstage human trials, was ...
... Pharmaceuticals, Inc. . Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline NEW BRUNSWICK, N.J., June ...
... Diego’s strong third quarter was led by investment in life-sciences companies, including Aragon Pharmaceuticals and Tandem Diabetes Care, which netted $50.1 million and $36.4 million ...
Want to see the full history on Aragon Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial